Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Global X SuperDividend REIT ETF
SRET
$230M
| $2.81M | ﹤0.01% |
119,413
+79,244
| +197% | +$1.71M |
|
3802
CALL
Principal Financial Group
PFG
$24.4B
| $2.8M | ﹤0.01% |
67,500
+38,200
| +130% | +$1.39M |
|
3803
PUT
Cameco
CCJ
$42.6B
| $2.8M | ﹤0.01% |
273,300
+17,700
| +7% | +$177K |
|
3804
CALL
NRG Energy
NRG
$26.5B
| $2.8M | ﹤0.01% |
86,000
-28,000
| -25% | -$922K |
|
3805
Seaboard Corp
SEB
$4.18B
| $2.8M | ﹤0.01% |
954
+394
| +70% | +$1.19M |
|
3806
CALL
Bio-Techne
TECH
$11.3B
| $2.8M | ﹤0.01% |
+42,400
| New | +$2.54M |
|
3807
CALL
Xcel Energy
XEL
$49.5B
| $2.79M | ﹤0.01% |
44,700
+19,300
| +76% | +$1.22M |
|
3808
iShares Core S&P Small-Cap ETF
IJR
$114B
| $2.79M | ﹤0.01% |
+40,896
| New | +$2.58M |
|
3809
Advanced Energy
AEIS
$13.2B
| $2.79M | ﹤0.01% |
41,198
+27,192
| +194% | +$1.62M |
|
3810
Delek US
DK
$4.01B
| $2.79M | ﹤0.01% |
160,355
-141,241
| -47% | -$2.7M |
|
3811
CALL
CryoPort
CYRX
$772M
| $2.79M | ﹤0.01% |
92,200
+61,700
| +202% | +$1.37M |
|
3812
CALL
Vanguard Dividend Appreciation ETF
VIG
$114B
| $2.79M | ﹤0.01% |
23,800
-4,100
| -15% | -$467K |
|
3813
CALL
Kratos Defense & Security Solutions
KTOS
$12.1B
| $2.79M | ﹤0.01% |
178,400
+69,100
| +63% | +$1.11M |
|
3814
PUT
Amdocs
DOX
$6.18B
| $2.78M | ﹤0.01% |
+45,700
| New | +$2.82M |
|
|
LKFT
3815
PUT
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
| $2.78M | ﹤0.01% |
14,100
+2,400
| +21% | +$497K |
|
|
3816
CALL
Cameco
CCJ
$42.6B
| $2.78M | ﹤0.01% |
271,300
+136,200
| +101% | +$1.36M |
|
3817
PUT
Grand Canyon Education
LOPE
$3.76B
| $2.78M | ﹤0.01% |
30,700
-9,500
| -24% | -$845K |
|
|
FLXN
3818
PUT
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.78M | ﹤0.01% |
211,100
+170,000
| +414% | +$1.76M |
|
3819
State Street SPDR S&P Global Infrastructure ETF
GII
$931M
| $2.77M | ﹤0.01% |
63,424
-8,301
| -12% | -$354K |
|
3820
Hercules Capital
HTGC
$3.13B
| $2.77M | ﹤0.01% |
264,763
-70,537
| -21% | -$716K |
|
|
CSW
3821
CSW Industrials
CSW
$5.62B
| $2.77M | ﹤0.01% |
40,094
+4,415
| +12% | +$298K |
|
3822
ProShares VIX Mid-Term Futures ETF
VIXM
$94.3M
| $2.77M | ﹤0.01% |
+68,825
| New | +$2.76M |
|
3823
Pan American Silver
PAAS
$19.7B
| $2.77M | ﹤0.01% |
91,015
-1,074,199
| -92% | -$25.5M |
|
3824
Leggett & Platt
LEG
$1.32B
| $2.76M | ﹤0.01% |
78,599
-151,448
| -66% | -$4.7M |
|
3825
PUT
Grocery Outlet
GO
$1.1B
| $2.76M | ﹤0.01% |
67,700
+29,100
| +75% | +$1.04M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.